Pure Biologics signs £32.44 mln agreement with ABM
12:25
Pure Biologics has signed an agreement with the Agency for Medical Research (ABM) to implement and fund a project to treat cancer (project PB004), the company said.
The project's total cost is PLN 48.9 million, and the allocated funding is PLN 32.44 million. The project funds can be spent between 2022 and 2026.
Source: ISB News
